dmPFC-vlPAG projection neurons contribute to pain threshold maintenance and antianxiety behaviors
Jun-Bin Yin,Shao-Hua Liang,Fei Li,Wen-Jun Zhao,Yang Bai,Yi Sun,Zhen-Yu Wu,Tan Ding,Yan Sun,Hai-Xia Liu,Ya-Cheng Lu,Ting Zhang,Jing Huang,Tao Chen,Hui Li,Zhou-Feng Chen,Jing Cao,Rui Ren,Ya-Nan Peng,Juan Yang,Wei-Dong Zang,Xiang Li,Yu-Lin Dong,Yun-Qing Li
DOI: https://doi.org/10.1172/jci127607
IF: 19.456
2020-11-03
Journal of Clinical Investigation
Abstract:The dorsal medial prefrontal cortex (dmPFC) has been recognized as a key cortical area for nociceptive modulation. However, the underlying neural pathway and the function of specific cell types remain largely unclear. Here, we show that lesions in the dmPFC induced an algesic and anxious state. Using multiple tracing methods including a rabies-based transsynaptic tracing method, we outlined an excitatory descending neural pathway from the dmPFC to the ventrolateral periaqueductal gray (vlPAG). Specific activation of the dmPFC/vlPAG neural pathway by optogenetic manipulation produced analgesic and antianxiety effects in a mouse model of chronic pain. Inhibitory neurons in the dmPFC were specifically activated using a chemogenetic approach, which logically produced an algesic and anxious state under both normal and chronic pain conditions. Antagonists of the GABA<sub>A</sub> receptor (GABA<sub>A</sub>R) or mGluR1 were applied to the dmPFC, which produced analgesic and antianxiety effects. In summary, the results of our study suggest that the dmPFC/vlPAG neural pathway might participate in the maintenance of pain thresholds and antianxiety behaviors under normal conditions, while silencing or suppressing the dmPFC/vlPAG pathway might be involved in the initial stages and maintenance of chronic pain and the emergence of anxiety-like behaviors.
medicine, research & experimental